Debate on the best first-line treatment for unmutated CLL: opinions from across the Atlantic
Overview of research in Waldenström’s macroglobulinemia therapies
Do immunoglobulin receptor interactions play a role in CLL?
Identification of high-risk disease using molecular profiling by Mymap
Highlights from ASH 2015 by Alan Burnett, MD on acute myeloid leukemia (AML)
Alan K. Burnett